Bibliography
- OTTE C, NABER D: Atypical antipsychotics in the treatment of schizophrenic patients. Expert Rev. Neurotherap. (2002) 2(3):355–362.
- KARAYIORGOU M: Genetic aspects of schizophrenia. Clin. Neurosci. Res. (2001) 1(1-2):158–163.
- MEADOR-WOODRUFF JH, HEALY DJ: Glutamate receptor expression in schizophrenic brain. Brain Res. Rev. (2000) 31(2/3):288–294.
- JENTSCH JD, ROTH RH: The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology (1999) 20(3):201–225.
- ••This review summarises the NMDAhypofunction hypothesis and agents that may correct it.
- WOOD PL: The NMDA receptor complex: a long and winding road to therapeutics. IDrugs (2005) 8(3):229–235.
- EULENBURG V, ARMSEN W, BETZ H, GOMEZA J: Glycine transporters: essential regulators of neurotransmission. Trends Biochem. Sci. (2005) 30(6):325–333.
- ARAGON C, LOPEZ-CORCUERA B: Glycine transporters: crucial roles of pharmacological interest revealed by gene deletion. Trends Pharmacol Sci. (2005) 26(6):283–286.
- ARAGON C, LOPEZ-CORCUERA B: Structure, function and regulation of glycine neurotransporters. Eur. Pharmacol (2003) 479(1-3):249–262.
- ••This review gives a definitive overview ofthe glycine transporters and their structure and function.
- KINNEY GG, SUR C: Glycine site modulators and glycine transporter-1 inhibitors as novel therapeutic targets for the treatment of schizophrenia. Curr. Neuropharmacol (2005) 3(1):35–43.
- JAVITT DC: Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiat. (2004) 9(10:984–997.
- ••This review summarises approaches toantipsychotic agents based on the NMDA receptor.
- HASHIMOTO K, OKAIVIURAN, SHIMIZU El, IYO M: Glutamate hypothesis of schizophrenia and approach for possible therapeutic drugs. Curr. Med. Chem. Central Nervous System Agents (2004) 4(2):147–154.
- SLASSI A, EGLE I: Recent progress in the use of glycine transporter-1 inhibitors for the treatment of central and peripheral nervous system diseases. Expert Opin. Ther. Patents (2004) 14(2):20i-2i4.
- SMITH G, RUHLAND T, MIKKELSEN G: The synthesis and SAR of 2-arylsulfanyl-phenyl piperazinyl acetic acids as G1yT-1 inhibitors. Bioorg Med. Chem. Lett. (2004) 14(15):4027–4030.
- DE BLAS J, CASTANO A, DAVISON JZ et al.: 17th International Symposium on Medicinal Chemistry. Barcelona, Spain (1–5 September 2002) Poster.
- DEPOORTERE R, DARGAZANLI G, ESTIENNE-BOUHTOU G et al.: Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 55R504734, a potential new type of antipsychotic, Neuropsychopharmacology (8 June 2005):1–23 online.
- ••This paper discloses the completecharacterisation of SSR-504734.